This Article Full Text Full Text (PDF) All Versions of this Article: 108/19/2368    most recent 01.CIR.0000101681.27911.FAv1 Alert me when this article is cited Alert me if a correction is posted Citation Map Services Email this article to a friend Similar articles in this journal Similar articles in PubMed Alert me to new issues of the journal Download to citation manager Request Permissions Citing Articles Citing Articles via HighWire Citing Articles via Google Scholar Google Scholar Articles by Ohuchi, H. Articles by Echigo, S. Search for Related Content PubMed PubMed Citation Articles by Ohuchi, H. Articles by Echigo, S. Pubmed/NCBI databases Compound via MeSH Substance via MeSH Medline Plus Health Information Congenital Heart Defects Heart Failure Hazardous Substances DB EPINEPHRINE Related Collections Pediatric and congenital heart disease, including cardiovascular surgery

(Circulation. 2003;108:2368.)
© 2003 American Heart Association, Inc.

Clinical Investigation and Reports

Stratification of Pediatric Heart Failure on the Basis of Neurohormonal and Cardiac Autonomic Nervous Activities in Patients With Congenital Heart Disease

Hideo Ohuchi, MD; Hisashi Takasugi, MD; Hiroyuki Ohashi, MD; Yoko Okada, MD; Osamu Yamada, MD; Yasuo Ono, MD; Toshikatsu Yagihara, MD; Shigeyuki Echigo, MD

From the Departments of Pediatrics (H. Ohuchi, H.T., H. Ohashi, Y. Okada, O.Y., Y. Ono, S.E.) and Thoracic Surgery (T.Y.), National Cardiovascular Center, Osaka, Japan.

Correspondence to Hideo Ohuchi, MD, Department of Pediatrics, National Cardiovascular Center, 5-7-1, Fujishiro-dai, Suita, Osaka 565-8565, Japan. E-mail hohuchi{at}hsp.ncvc.go.jp

Received February 18, 2003; de novo received June 12, 2003; revision received August 13, 2003; accepted August 14, 2003.

Background— Stratification of pediatric patients with congenital heart disease (CHD) has been based on their hemodynamics and/or functional capacity. Our purpose was to compare cardiac autonomic nervous activity (CANA) and neurohormonal activities (NHA) with postoperative status in stable CHD patients with biventricular physiology.

Methods and Results— We divided 379 subjects (297 CHD patients, 28 dilated cardiomyopathy patient, and 54 control subjects) into 4 subgroups according to New York Heart Association (NYHA) class (1.3±0.7) and measured various CANA and NHA indices. Stepwise decreases in baroreflex sensitivity (BRS), heart rate variability (HRV), adrenergic imaging, and vital capacity (VC) were observed in proportion to functional capacity in normal to NYHA II patients (P<0.001). However, there were no differences in these indices between NYHA II and III+IV groups, whereas a stepwise proportional increase in NHA indices was observed in these groups (P<0.001). Natriuretic peptides differentiated all NYHA classes. BRS, HRV, and VC were greater in the adult patients than in the child patients (P<0.05 to 0.01), although the functional class in adult patients was lower. Cardiac surgeries resulted in low BRS and VC, and the VC reduction independently determined a small HRV. Even if functional class and ejection fraction were comparable, CANA and brain natriuretic peptide were lower in CHD patients than in dilated cardiomyopathy patients (P<0.05 to 0.001).

Conclusions— CANA and NHA indices are useful to stratify mild and severe heart failure in stable postoperative CHD patients, respectively. However, careful attention should be paid to age- and surgery-related influences on these indices.

Key Words: heart defects, congenital • nervous system, autonomic • hormones • heart failure

This article has been cited by other articles:

				M Carlson and M Silberbach Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature BMJ Case Reports, July 1, 2009; 2009(jul01_1): bcr0620091998 - bcr0620091998. [Abstract] [Full Text]

				D. T. Hsu and G. D. Pearson Heart Failure in Children: Part I: History, Etiology, and Pathophysiology Circ Heart Fail, January 1, 2009; 2(1): 63 - 70. [Full Text] [PDF]

				J. Mangat, C. Carter, G. Riley, Y. Foo, and M. Burch The clinical utility of brain natriuretic peptide in paediatric left ventricular failure Eur J Heart Fail, January 1, 2009; 11(1): 48 - 52. [Abstract] [Full Text] [PDF]

				M.-K. Yum, J.-T. Kim, and H.-S. Kim Increased non-stationarity of heart rate during general anaesthesia with sevoflurane or desflurane in children Br. J. Anaesth., June 1, 2008; 100(6): 772 - 779. [Abstract] [Full Text] [PDF]

				M Carlson and M Silberbach Dissection of the aorta in Turner syndrome: two cases and review of 85 cases in the literature J. Med. Genet., December 1, 2007; 44(12): 745 - 749. [Abstract] [Full Text] [PDF]

				C. E. Canter, R. E. Shaddy, D. Bernstein, D. T. Hsu, M. R.K. Chrisant, J. K. Kirklin, K. R. Kanter, R. S.D. Higgins, E. D. Blume, D. N. Rosenthal, et al. Indications for Heart Transplantation in Pediatric Heart Disease: A Scientific Statement From the American Heart Association Council on Cardiovascular Disease in the Young; the Councils on Clinical Cardiology, Cardiovascular Nursing, and Cardiovascular Surgery and Anesthesia; and the Quality of Care and Outcomes Research Interdisciplinary Working Group Circulation, February 6, 2007; 115(5): 658 - 676. [Abstract] [Full Text] [PDF]

				J. F. Price, A. K. Thomas, M. Grenier, B. W. Eidem, E. O. Smith, S. W. Denfield, J. A. Towbin, and W. J. Dreyer B-Type Natriuretic Peptide Predicts Adverse Cardiovascular Events in Pediatric Outpatients With Chronic Left Ventricular Systolic Dysfunction Circulation, September 5, 2006; 114(10): 1063 - 1069. [Abstract] [Full Text] [PDF]

				A. Hammerer-Lercher, R. Geiger, J. Mair, C. Url, G. Tulzer, E. Lechner, B. Puschendorf, and R. Sommer Utility of N-Terminal Pro-B-Type Natriuretic Peptide to Differentiate Cardiac Diseases from Noncardiac Diseases in Young Pediatric Patients Clin. Chem., July 1, 2006; 52(7): 1415 - 1419. [Abstract] [Full Text] [PDF]

				R. G. Williams, G. D. Pearson, R. J. Barst, J. S. Child, P. del Nido, W. M. Gersony, K. S. Kuehl, M. J. Landzberg, M. Myerson, S. R. Neish, et al. Report of the National Heart, Lung, and Blood Institute Working Group on Research in Adult Congenital Heart Disease J. Am. Coll. Cardiol., February 21, 2006; 47(4): 701 - 707. [Abstract] [Full Text] [PDF]

				K. Norozi, R. Buchhorn, C. Kaiser, G. Hess, R. W. Grunewald, L. Binder, and A. Wessel Plasma N-Terminal Pro-Brain Natriuretic Peptide as a Marker of Right Ventricular Dysfunction in Patients With Tetralogy of Fallot After Surgical Repair Chest, October 1, 2005; 128(4): 2563 - 2570. [Abstract] [Full Text] [PDF]

				J. M. Costello, C. L. Backer, P. A. Checchia, C. Mavroudis, R. G. Seipelt, and D. M. Goodman Effect of cardiopulmonary bypass and surgical intervention on the natriuretic hormone system in children J. Thorac. Cardiovasc. Surg., September 1, 2005; 130(3): 822 - 829. [Abstract] [Full Text] [PDF]

				H. Ohuchi, H. Takasugi, H. Ohashi, O. Yamada, K. Watanabe, T. Yagihara, and S. Echigo Abnormalities of Neurohormonal and Cardiac Autonomic Nervous Activities Relate Poorly to Functional Status in Fontan Patients Circulation, October 26, 2004; 110(17): 2601 - 2608. [Abstract] [Full Text] [PDF]